Sun Pharmaceutical Industries Ltd. | SUNPHARMA | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Net Income
Net Income
38,102
50,096
27,994
44,813
94,084
Cash flow Operating Act...
Cash flow Operating Activities
21,96565,54861,70489,84549,593
Investments in PPE
Investments in PPE
-32,128-15,420-11,701-14,950-20,856
Cash flow Investing Act...
Net cash used for Investment Activities
-6,813-25,8885,362-57,247-79,437
Dividend Paid
Dividend Paid
14,24216,82815,86221,69225,197
Cash flow Financing Act...
Net cash provided by Financing Activities
-27,305-57,151-59,805-51,93523,761
Cash at beginning of period
Cash at beginning of period
79,06570,62356,76662,73045,083
Cash at end of period
Cash at end of period
70,62356,76662,73045,08346,237
Free Cash Flow
Free Cash Flow
-10,164
50,128
50,002
74,895
28,738